(2009). Microlaryngoscopic and office-based injection of bevacizumab (avastin) to enhance 532-nm pulsed KTP laser treatment of glottal papillomatosis. Annals Publ. Co.
Chicago-Zitierstil (17. Ausg.)Microlaryngoscopic and Office-based Injection of Bevacizumab (avastin) to Enhance 532-nm Pulsed KTP Laser Treatment of Glottal Papillomatosis. St. Louis, MO: Annals Publ. Co, 2009.
MLA-Zitierstil (9. Ausg.)Microlaryngoscopic and Office-based Injection of Bevacizumab (avastin) to Enhance 532-nm Pulsed KTP Laser Treatment of Glottal Papillomatosis. Annals Publ. Co, 2009.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.